ACHE and Alzheimer disease: So, over the last two decades, acetylcholinesterase (AChE) has been the focus of intensive pharmaceutical research, resulting in the development of several drugs currently in clinical use for the treatment of AD, with AChE inhibitors constituting many drugs approved by the FDA for the disease [6, 7].